Genetic Influences on Occurrence of Axial Spondyloarthritis (axSpA) in First-degree Relatives During a Prospective Study Lasting 35 Years Muhammad Asim A. Khan, MD, FRCP – Case Western Reserve University School of Medicine,, Cleveland OH
9:00 AM – 11:00 AM ET
Clinical History as Tool for Diagnosis and Classification of Patients with Ankylosing Spondylitis (Axial Spondyloarthritis): Evidence from a 35-Year Follow-up Family Study of a Swiss Cohort Sjef M. Van Der Linden, MD – University of Bern
9:00 AM – 11:00 AM ET
How to Diagnose Axial Spondyloarthritis in 2020? A Data-Driven Estimation of the Disease Probability in Patients with a priori Different Likelihoods of the Diagnosis Denis Poddubnyy, MD, MSc – Charité - Universitätsmedizin Berlin
9:00 AM – 11:00 AM ET
Identification of Parameters Associated with a Diagnostic Delay in Axial Spondyloarthritis:Results from the European Map of Axial Spondyloarthritis (EMAS) Denis Poddubnyy, MD, MSc – Charité - Universitätsmedizin Berlin
9:00 AM – 11:00 AM ET
Patient-reported Impact of Axial Spondyloarthritis on Working Life. Results from the Spanish Atlas 2017 Marco Garrido-Cumbrera, PhD – University of Seville
9:00 AM – 11:00 AM ET
Two-Year Diagnostic Consistency in Patients with Chronic Back Pain Suspected of Axial Spondyloarthritis in Protocolised Follow-up: Data from the Spondyloarthritis Caught Early Cohort Anne Boel, MSc – Leiden University Medical Centre
9:00 AM – 11:00 AM ET
Comparison of Quality of Life Between Chronic Back Pain Patients with and Without a Diagnosis of Axial Spondyloarthritis After 2-Year Protocolised Follow-up: Data from the Spondyloarthritis Caught Early Cohort Anne Boel, MSc – Leiden University Medical Centre
9:00 AM – 11:00 AM ET
“Rheum to Diagnosis”: Uncovering Impediments to Accurate Diagnosis of Non-radiographic Axial Spondylarthritis (nr-axSpA) Sonam Kiwalkar, MD – Oregon Health & Science University
9:00 AM – 11:00 AM ET
Development of Candidate Criteria for Axial Disease in Juvenile Spondyloarthritis: An International Collaboration Pamela Weiss, MD, MSCE – Children's Hospital of Philadelphia
9:00 AM – 11:00 AM ET
Comparison of Work Productivity Outcomes Between Chronic Back Pain Patients with and Without a Diagnosis of Axial Spondyloarthritis After 2-Year Protocolised Follow-Up: Data from the Spondyloarthritis Caught Early Cohort Anne Boel, MSc – Leiden University Medical Centre
9:00 AM – 11:00 AM ET
Relative Associations of Sociodemographic, Clinical and HLA-B Alleles with Enthesitis and Peripheral Arthritis in Patients with Ankylosing Spondylitis Benjamin S. Naovarat, MD – University of Texas Health Science Center at Houston John P. and Kathrine G. McGovern Medical School
9:00 AM – 11:00 AM ET
The Changing Profile of Ankylosing Spondylitis in the Biologic Era Lauren Ridley, MD – McGovern Medical School
9:00 AM – 11:00 AM ET
Differences Between Men and Women in the Patient Pathways to Diagnosis of Ankylosing Spondylitis Mark C. Hwang, MD – McGovern Medical School at the University of Texas Health Science Center at Houston
9:00 AM – 11:00 AM ET
Heterogeneity Amongst Men and Women with Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis Zhixiu Li, PhD – QUT
9:00 AM – 11:00 AM ET
The Role of HLA B27 in Axial Spondyloarthritis: Prevalence and Performance as a Marker in an Argentinian Cohort Rodrigo Garcia Salinas, MD – Hospital Italiano de La Plata
9:00 AM – 11:00 AM ET
Diagnosis of Axial Spondyloarthritis: A Primary Unmet Educational Need for Rheumatologists Is Interpretation of MRI Walter P. Maksymowych, MD, FRCPC – University of Alberta
9:00 AM – 11:00 AM ET
Consensus Definitions for MRI Lesions in the Spine of Patients with Axial Spondyloarthritis: First Analysis from the Assessments in SpondyloArthritis International Society Classification Cohort Walter P. Maksymowych, MD, FRCPC – University of Alberta
9:00 AM – 11:00 AM ET
Development of a Deep Learning Algorithm to Predict Positive MRI of the Sacroiliac Joints According to the ASAS Definition in Patients with Recent Axial Spondyloarthritis Clementina Lopez-Medina, PhD – Cochin Hospital, Rheumatology Department
9:00 AM – 11:00 AM ET
Association of Healthcare Utilization and Costs with Patient-Reported Outcomes in Patients with Ankylosing Spondylitis Alexis Ogdie, MD, MSCE – University of Pennsylvania
9:00 AM – 11:00 AM ET
In Radiographic Axial Spondyloarthritis, Bridging Syndesmophytes Increase Risk of Facet Joint Ankylosis Development on the Same Vertebral Level While Facet Joint Ankylosis Does Not Increase Risk of Same Level Syndesmophytes Development Rosalinde Stal, MSc – Leiden University Medical Center
9:00 AM – 11:00 AM ET
Are There Any Clues to Predict Bamboo Spine in Axial Spondyloarthritis? Pamir Atagunduz, MD – Marmara University School of Medicine
9:00 AM – 11:00 AM ET
Exercise Partially Explains the Impact of Body Mass Index on Disease Activity in Ankylosing Spondylitis Jean W. Liew, MD – Boston University
9:00 AM – 11:00 AM ET
Disease Activity in an Axial Spondyloarthritis Cohort During the COVID-19 Pandemic Jean W. Liew, MD – Boston University
9:00 AM – 11:00 AM ET
Performance of SASDAS (Simplified Axial Spondyloarthritis Disease Activity Score) versus ASDAS in a Post Hoc Analysis of a Randomized Controlled Clinical Trial Emilce E. Schneeberger, MD – Instituto de Rehabilitación Psicofísica
9:00 AM – 11:00 AM ET
Measuring Physical Activity in AxSpA:Content Validity and Measurement Properties of the New AxSpA-SQUASH Marlies Carbo, MD – University Medical Centre Groningen
9:00 AM – 11:00 AM ET
Spinal Mobility and Function: How Closely Do They Associate in Axial Spondyloarthropathy? Sinead Maguire, MD – St James' Hospital
9:00 AM – 11:00 AM ET
Successful Evaluation of Spinal Mobility Measurements with the Epionics SPINE Device in Patients with Axial Spondyloarthritis Compared to Controls David Kiefer, MD – Ruhr-Universität Bochum
9:00 AM – 11:00 AM ET
Reliability and Validity of the PROMIS-29 Health Profile in Ankylosing Spondylitis Patients Yvette Farran, MD – UT Houston
9:00 AM – 11:00 AM ET
Daily Management of Patients with Axial Spondyloarthritis: Self-monitoring of Disease Activity with a Smartphone App Is Feasible – a Proof of Concept Study Uta Kiltz, MD – Rheumazentrum Ruhrgebiet, Ruhr-University Bochum
9:00 AM – 11:00 AM ET
Impact of Utilising Smart Phone Application in Ankylosing Spondylitis: SMART- as Study Ashit Syngle, MD, FRCP – Healing Touch City Clinic
9:00 AM – 11:00 AM ET
Pattern and Influential Factors in Promoting Treat-to-Target (T2T) for F Ankylosing Spondylitis (AS) Patients with the App of Smart System of Disease Management (SSDM): A Cohort Study from China Jing Xue, MD – Second Affiliated Hospital，Zhejiang University School of Medcine
9:00 AM – 11:00 AM ET
Predictors of Response in Secukinumab-treated Patients with Ankylosing Spondylitis: Logistic Regression and Machine Learning Analyses Corinne Miceli-Richard – Assistance Publique Hôpitaux de PAris
9:00 AM – 11:00 AM ET
Use of Facebook and Electronic Patient Portal to Identify Axial Spondyloarthritis in Patients with Chronic Back Pain Yuliya Afinogenova, MD – Yale
9:00 AM – 11:00 AM ET
Radiographic Progression in Patients with Axial Spondyloarthritis Under Treatment with TNF Inhibitors. Data from REGISPONSERBIO (Spanish Register of Biological Therapy in Spondyloarthritides) María Llop Vilaltella, MD – Parc Tauli Hospital Universitari
9:00 AM – 11:00 AM ET
No Relationship Between Lumbar Bone Mineral Density and Syndesmophyte Formation at the Same Level - A Multilevel Analysis in Patients with Radiographic Axial Spondyloarthritis Mary Lucy Marques, MD – Leiden University Medical Center
9:00 AM – 11:00 AM ET
Trends in Hospitalizations for Vertebral Compression Fractures in Ankylosing Spondylitis: Data from the National Inpatient Sample 2001-2014 Anish Paudel, MD – reading hospital
9:00 AM – 11:00 AM ET
Comparative Effectiveness of Secukinumab, Adalimumab and Other Tumor Necrosis Factor Inhibitors in the Treatment of Axial Spondyloarthritis Loïc Choquette Sauvageau, BSc – Institut de Rhumatologie de Montréal
9:00 AM – 11:00 AM ET
Life Expectancy a Swiss Cohort of Patients with Ankylosing Spondylitis: A 35-Year Follow-up Study Zhixiu Li, PhD – QUT
9:00 AM – 11:00 AM ET
The Clinical and the Functional Impact of Central Sensitization on Patients with Axial Spondyloarthritis Mehmet Tuncay Duruöz, MD – Marmara University School of Medicine, PMR Department, Rheumatology Division
9:00 AM – 11:00 AM ET
Clinical Characteristics of Importance to Outcome in Patients with Axial Spondyloarthritis: A Prospective Cohort Study Rikke Asmussen Andreasen, MD, PhD – Odense University Hospital, Svendborg
9:00 AM – 11:00 AM ET
Determinants of Physician Global Assessment and Influence of Contextual Factors in Early Axial Spondyloarthritis Fumio Hirano, MD, PhD – Nissan Tamagawa Hospital
9:00 AM – 11:00 AM ET
Assessment of Global DNA Methylation in Peripheral Blood Cell Subpopulations of Patients with Axial Spondyloarthritis : Preliminary Results Eric Toussirot, MD – University Hospital Besancon
9:00 AM – 11:00 AM ET
Clinical Features of Patients with Active Ankylosing Spondylitis Who Did Not Respond to Adalimumab but Responded to Ixekizumab: A Post-hoc Analysis Xenofon Baraliakos, MD – Rheumazentrum Ruhrgebiet Herne
